Protagonist Therapeutics, Inc. (PTGX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Protagonist Therapeutics, Inc. (PTGX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

PTGX Income Statement

Protagonist Therapeutics, Inc. (PTGX) annual income statement — 12-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	274.41M	213.47M	56.37M	7.44M	4.71M	5.55M	28.32M	170.64M	4.67M	4.17M	254.95M	60M	0	0	0	0	0	859K	25.72M	8.62M
Revenue Growth %	5723.64%	3749.17%	99.03%	-95.64%	0.79%	33.09%	-88.89%	184.4%	-	-	-	-	-	-100%	-100%	-100%	-100%	-62.08%	315.61%	52.51%
Cost of Goods Sold	1.1M	0	407K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	843K	833K	819K
COGS % of Revenue	0.4%	-	0.72%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	98.14%	3.24%	9.5%
Gross Profit	273.31M	213.47M	55.96M	7.44M	4.71M	5.55M	28.32M	170.64M	4.67M	4.17M	254.95M	60M	0	0	0	0	0	16K	24.89M	7.8M
Gross Margin %	99.6%	100%	99.28%	100%	100%	100%	100%	100%	100%	100%	100%	100%	-	-	-	-	-	1.86%	96.76%	90.5%
Gross Profit Growth %	5700.3%	3749.17%	97.6%	-95.64%	0.79%	33.09%	-88.89%	184.4%	-	-	-	-	-	-100%	-100%	-100%	-100%	-99.29%	302.15%	38.02%
Operating Expenses	54.98M	54.71M	59.61M	57.79M	51.13M	47.59M	47.63M	43.86M	46.13M	42.96M	48.64M	36.95M	38.33M	42.35M	36.02M	36.52M	32.3M	41.46M	46M	45.71M
OpEx % of Revenue	20.04%	25.63%	105.75%	777.09%	1085.17%	858.04%	168.18%	25.7%	986.7%	1030.96%	19.08%	61.59%	-	-	-	-	-	4826.43%	178.84%	530.51%
Selling, General & Admin	13.7M	12.65M	13.28M	11.43M	11.13M	10.55M	11.74M	8.95M	10.16M	9.44M	14.91M	8.05M	7.66M	9.17M	8.61M	6.63M	6.9M	6.85M	9.68M	6.44M
SG&A % of Revenue	4.99%	5.92%	23.55%	153.74%	236.21%	190.25%	41.45%	5.25%	217.28%	226.54%	5.85%	13.42%	-	-	-	-	-	797.21%	37.64%	74.75%
Research & Development	41.27M	42.06M	46.74M	46.36M	40M	37.04M	35.89M	34.9M	35.97M	33.52M	33.73M	28.9M	30.66M	33.18M	27.42M	29.88M	25.4M	34.61M	36.32M	39.27M
R&D % of Revenue	15.04%	19.7%	82.92%	623.34%	848.96%	667.8%	126.74%	20.46%	769.41%	804.42%	13.23%	48.16%	-	-	-	-	-	4029.22%	141.19%	455.76%
Other Operating Expenses	0	0	-407K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	218.33M	158.77M	-3.65M	-50.35M	-46.42M	-42.04M	-19.31M	126.78M	-41.45M	-38.79M	206.31M	23.05M	-38.33M	-42.35M	-36.02M	-36.52M	-32.3M	-41.44M	-21.11M	-37.92M
Operating Margin %	79.56%	74.37%	-6.47%	-677.09%	-985.17%	-758.04%	-68.18%	74.3%	-886.7%	-930.96%	80.92%	38.41%	-	-	-	-	-	-4824.56%	-82.07%	-440.01%
Operating Income Growth %	570.33%	477.65%	81.11%	-139.72%	-11.98%	-8.37%	-109.36%	450.05%	-8.16%	8.41%	672.75%	163.12%	-18.65%	-2.2%	-70.63%	3.69%	4.78%	-34.2%	12.11%	-101.36%
EBITDA	226.57M	159.16M	-3.24M	-49.98M	-46.06M	-41.74M	-19.07M	127.32M	-40.81M	-37.32M	206.54M	23.88M	-37.5M	-41.53M	-35.19M	-35.68M	-31.45M	-40.6M	-20.28M	-37.1M
EBITDA Margin %	82.57%	74.56%	-5.75%	-672.03%	-977.5%	-752.56%	-67.34%	74.61%	-872.86%	-895.54%	81.01%	39.8%	-	-	-	-	-	-4726.43%	-78.84%	-430.51%
EBITDA Growth %	591.9%	481.35%	83.01%	-139.26%	-12.88%	-11.84%	-109.23%	433.13%	-8.82%	10.15%	686.96%	166.94%	-19.23%	-2.3%	-73.53%	3.83%	5.33%	-32.26%	14.94%	-100.71%
D&A (Non-Cash Add-back)	0	397K	407K	376K	361K	304K	239K	536K	647K	1.48M	236K	832K	827K	821K	832K	840K	853K	843K	833K	819K
EBIT	226.57M	165.11M	2.28M	-43.72M	-39.34M	-34.6M	-11.65M	133.66M	-33.63M	-31.29M	210.67M	23.05M	-38.33M	-42.35M	-36.02M	-32.54M	-32.3M	-41.04M	-20.93M	-37.81M
Net Interest Income	8.25M	6.43M	5.88M	6.76M	7.05M	7.41M	7.57M	6.85M	7.68M	7.4M	4.38M	4.24M	4.25M	3.91M	2.49M	2.25M	1.16M	484K	168K	122K
Interest Income	8.25M	6.43M	5.88M	6.76M	7.05M	7.41M	7.57M	6.85M	7.68M	7.4M	4.38M	4.24M	4.25M	3.91M	2.49M	2.25M	1.16M	484K	168K	122K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	8.24M	6.35M	5.93M	6.64M	7.08M	7.44M	7.66M	6.88M	7.82M	7.5M	4.36M	4.29M	4.22M	3.89M	2.3M	2.32M	1.07M	406K	181K	109K
Pretax Income	226.57M	165.11M	2.28M	-43.72M	-39.34M	-34.6M	-11.65M	133.66M	-33.63M	-31.29M	210.67M	27.34M	-34.1M	-38.46M	-33.73M	-34.19M	-31.23M	-41.04M	-20.93M	-37.81M
Pretax Margin %	82.57%	77.35%	4.05%	-587.84%	-834.87%	-623.86%	-41.15%	78.33%	-719.36%	-750.95%	82.63%	45.56%	-	-	-	-	-	-4777.3%	-81.37%	-438.75%
Income Tax	6.56M	2.27M	-1.5M	666K	0	172K	0	1.99M	-420K	-676K	3.33M	0	0	0	0	0	0	0	0	-900K
Effective Tax Rate %	2.89%	1.37%	-65.85%	-1.52%	0%	-0.5%	0%	1.49%	1.25%	2.16%	1.58%	0%	0%	0%	0%	0%	0%	0%	0%	2.38%
Net Income	220.01M	162.85M	3.78M	-44.38M	-39.34M	-34.77M	-11.65M	131.67M	-33.21M	-30.62M	207.34M	27.34M	-34.1M	-38.46M	-33.73M	-34.19M	-31.23M	-41.04M	-20.93M	-36.91M
Net Margin %	80.18%	76.28%	6.71%	-596.8%	-834.87%	-626.96%	-41.15%	77.17%	-710.37%	-734.73%	81.32%	45.56%	-	-	-	-	-	-4777.3%	-81.37%	-428.3%
Net Income Growth %	659.28%	568.35%	132.46%	-133.71%	-18.46%	-13.57%	-105.62%	381.7%	2.62%	20.4%	714.8%	179.94%	-9.2%	6.28%	-61.13%	7.35%	7.61%	-33.06%	12.78%	-95.42%
Net Income (Continuing)	220.01M	162.85M	3.78M	-44.38M	-39.34M	-34.77M	-11.65M	131.67M	-33.21M	-30.62M	207.34M	27.34M	-34.1M	-38.46M	-33.73M	-34.19M	-31.23M	-41.04M	-20.93M	-36.91M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	3.07	2.29	0.05	-0.69	-0.62	-0.55	-0.19	1.98	-0.54	-0.50	3.26	0.44	-0.58	-0.68	-0.62	-0.64	-0.61	-0.83	-0.43	-0.77
EPS Growth %	595.16%	516.36%	128.26%	-134.85%	-14.81%	-10%	-105.83%	350%	6.9%	26.47%	625.81%	168.75%	4.92%	18.07%	-44.19%	16.88%	12.86%	-20.29%	20.37%	-60.42%
EPS (Basic)	3.32	2.47	0.06	-0.69	-0.62	-0.55	-0.19	2.11	-0.54	-0.50	3.41	0.45	-0.58	-0.68	-0.62	-0.64	-0.62	-0.83	-0.43	-0.77
Diluted Shares Outstanding	71.73M	71.01M	70.49M	63.57M	63.77M	63.51M	62.96M	66.41M	61.77M	61.31M	63.6M	61.8M	59.18M	56.78M	50.57M	49.26M	49.11M	49.05M	48.75M	48.15M
Basic Shares Outstanding	66.36M	65.94M	65.09M	63.57M	63.77M	63.51M	62.96M	62.33M	61.77M	61.31M	60.86M	60.39M	59.18M	56.78M	50.57M	49.26M	48.8M	48.85M	48.67M	48.15M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-